Lauruschkat CD - Search Results

1

Chronic Occupational Mold Exposure Drives Expansion of Aspergillus-Reactive Type 1 and Type 2 T-Helper Cell Responses.

Lauruschkat CD, Etter S, Schnack E, Ebel F, Schäuble S, Page L, Rümens D, Dragan M, Schlegel N, Panagiotou G, Kniemeyer O, Brakhage AA, Einsele H, Wurster S, Loeffler J. Lauruschkat CD, et al. J Fungi (Basel). 2021 Aug 27;7(9):698. doi: 10.3390/jof7090698. J Fungi (Basel). 2021. PMID: 34575736 Free PMC article.

2

Susceptibility of A. fumigatus-specific T-cell assays to pre-analytic blood storage and PBMC cryopreservation greatly depends on readout platform and analytes.

Lauruschkat CD, Wurster S, Page L, Lazariotou M, Dragan M, Weis P, Ullmann AJ, Einsele H, Löffler J. Lauruschkat CD, et al. Mycoses. 2018 Aug;61(8):549-560. doi: 10.1111/myc.12780. Epub 2018 Jun 11. Mycoses. 2018. PMID: 29611226

3

Immunomodulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives.

Lauruschkat CD, Einsele H, Loeffler J. Lauruschkat CD, et al. J Fungi (Basel). 2018 Dec 14;4(4):137. doi: 10.3390/jof4040137. J Fungi (Basel). 2018. PMID: 30558125 Free PMC article. Review.

4

Development and evaluation of a whole blood-based approach for flow cytometric quantification of CD154+ mould-reactive T cells.

Weis P, Helm J, Page L, Lauruschkat CD, Lazariotou M, Einsele H, Loeffler J, Ullmann AJ, Wurster S. Weis P, et al. Among authors: lauruschkat cd. Med Mycol. 2020 Feb 1;58(2):187-196. doi: 10.1093/mmy/myz038. Med Mycol. 2020. PMID: 31095327

5

Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154⁺ Aspergillus fumigatus specific T-cell quantification.

Page L, Lauruschkat CD, Helm J, Weis P, Lazariotou M, Einsele H, Ullmann AJ, Loeffler J, Wurster S. Page L, et al. Among authors: lauruschkat cd. Med Microbiol Immunol. 2020 Oct;209(5):579-592. doi: 10.1007/s00430-020-00665-3. Epub 2020 Mar 31. Med Microbiol Immunol. 2020. PMID: 32236695

6

T-Cell Immune Surveillance in Allogenic Stem Cell Transplant Recipients: Are Whole Blood-Based Assays Ready to Challenge ELISPOT?

Lauruschkat CD, Page L, Etter S, Weis P, Gamon F, Kraus S, Einsele H, Wurster S, Loeffler J. Lauruschkat CD, et al. Open Forum Infect Dis. 2020 Nov 8;8(1):ofaa547. doi: 10.1093/ofid/ofaa547. eCollection 2021 Jan. Open Forum Infect Dis. 2020. PMID: 33447629 Free PMC article.

7

Development of a Simple and Robust Whole Blood Assay with Dual Co-Stimulation to Quantify the Release of T-Cellular Signature Cytokines in Response to Aspergillus fumigatus Antigens.

Lauruschkat CD, Page L, White PL, Etter S, Davies HE, Duckers J, Ebel F, Schnack E, Backx M, Dragan M, Schlegel N, Kniemeyer O, Brakhage AA, Einsele H, Loeffler J, Wurster S. Lauruschkat CD, et al. J Fungi (Basel). 2021 Jun 8;7(6):462. doi: 10.3390/jof7060462. J Fungi (Basel). 2021. PMID: 34201183 Free PMC article.

8

COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds.

Tappe B, Lauruschkat CD, Strobel L, Pantaleón García J, Kurzai O, Rebhan S, Kraus S, Pfeuffer-Jovic E, Bussemer L, Possler L, Held M, Hünniger K, Kniemeyer O, Schäuble S, Brakhage AA, Panagiotou G, White PL, Einsele H, Löffler J, Wurster S. Tappe B, et al. Among authors: lauruschkat cd. Front Immunol. 2022 Aug 16;13:954985. doi: 10.3389/fimmu.2022.954985. eCollection 2022. Front Immunol. 2022. PMID: 36052094 Free PMC article.

9

CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis.

Lauruschkat CD, Muchsin I, Rein A, Erhard F, Grathwohl D, Dölken L, Köchel C, Falk CS, Einsele H, Wurster S, Grigoleit GU, Kraus S. Lauruschkat CD, et al. Front Immunol. 2023 May 10;14:1148841. doi: 10.3389/fimmu.2023.1148841. eCollection 2023. Front Immunol. 2023. PMID: 37234158 Free PMC article.

10

Impaired T and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation.

Lauruschkat CD, Muchsin I, Rein AF, Erhard F, Grathwohl D, Dölken L, Köchel C, Nehmer A, Falk CS, Grigoleit GU, Einsele H, Wurster S, Kraus S. Lauruschkat CD, et al. Blood Adv. 2024 Feb 5:bloodadvances.2023012008. doi: 10.1182/bloodadvances.2023012008. Online ahead of print. Blood Adv. 2024. PMID: 38315873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page